Key result
Higher cerebrospinal fluid ACE activity was associated with a reduced risk of global cortical atrophy.
Why the study?
Are higher serum and CSF ACE protein levels and activity associated with reduced brain atrophy and cerebral small vessel disease in memory clinic patients?
Cross-Sectional (n=118)
Are higher serum and CSF ACE protein levels and activity associated with reduced brain atrophy and cerebral small vessel disease in memory clinic patients?
Higher CSF ACE activity is associated with a reduced risk of global brain atrophy, suggesting ACE inhibitors may not be the preferred antihypertensive in patients at risk for Alzheimer's disease.
Answers are grounded in this paper and cite their sources.
Higher CSF ACE activity was associated with less atrophy in memory clinic patients; hypothesis-generating for ACE modulation in neurodegeneration and requires prospective confirmation.
BACKGROUND: Higher angiotensin-converting enzyme (ACE) activity might increase the risk of Alzheimer's disease by increasing blood pressure, and subsequent development of cerebral small vessel disease (CSVD). Yet, it may also decrease this risk, as it functions to degrade amyloid-β, thereby reducing brain atrophy. OBJECTIVE: To examine the cross-sectional associations of serum and cerebrospinal fluid (CSF) ACE protein levels and activity with brain atrophy and CSVD in a memory clinic cohort. METHODS: In 118 subjects from the memory clinic based Amsterdam Dementia Cohort (mean age 66 ± 8 years), ACE protein levels (ng/ml) and activity in CSF and serum were investigated. Poisson regression analyses were used to associate ACE measurements with rated global cortical atrophy, medial temporal lobe atrophy, lacunar infarcts, white matter hyperintensities, and microbleeds on brain MRI. RESULTS: Higher CSF ACE activity was associated with a reduced risk of global brain atrophy. The relative risk (95% CI) of having global cortical atrophy ≥2 per SD increase in CSF ACE activity was 0.67 (0.49; 0.93). ACE levels were not significantly related to measures of CSVD. CONCLUSIONS: These results show that high ACE might have protective effects on the brain. This could suggest that ACE inhibitors, which may lower CSF ACE levels, are not preferred as antihypertensive treatment in patients at risk for Alzheimer's disease.
No takes yet. Share an insight, caveat, or question.
Jochemsen et al. (2015) conducted a cross-sectional in Risk of Alzheimer's disease (n=118). Cerebrospinal fluid (CSF) ACE activity vs. Lower CSF ACE activity was evaluated on Global cortical atrophy ≥2 (RR 0.67, 95% CI 0.49-0.93). Higher cerebrospinal fluid ACE activity was associated with a reduced risk of global cortical atrophy.
Synapse has enriched 10 related papers. Consider them for comparative context: